title: Chemical blocking of zinc ions in CNS increases neuronal damage following traumatic brain injury (TBI) in mice.
abstract: BACKGROUND
  Traumatic brain injury (TBI) is one of the leading causes of disability and death among young people. Although much is already known about secondary brain damage the full range of brain tissue responses to TBI remains to be elucidated. A population of neurons located in cerebral areas associated with higher cognitive functions harbours a vesicular zinc pool co-localized with glutamate. This zinc enriched pool of synaptic vesicles has been hypothesized to take part in the injurious signalling cascade that follows pathological conditions such as seizures, ischemia and traumatic brain injury. Pathological release of excess zinc ions from pre-synaptic vesicles has been suggested to mediate cell damage/death to postsynaptic neurons.
  
  
  RESULTS
  In order to substantiate the influence of vesicular zinc ions on TBI, we designed a study in which damage and zinc movements were analysed in several different ways. Twenty-four hours after TBI ZnT3-KO mice (mice without vesicular zinc) were compared to littermate Wild Type (WT) mice (mice with vesicular zinc) with regard to histopathology. Furthermore, in order to evaluate a possible neuro-protective dimension of chemical blocking of vesicular zinc, we treated lesioned mice with either DEDTC or selenite. Our study revealed that chemical blocking of vesicular zinc ions, either by chelation with DEDTC or accumulation in zinc-selenium nanocrystals, worsened the effects on the aftermath of TBI in the WT mice by increasing the number of necrotic and apoptotic cells within the first 24 hours after TBI, when compared to those of chemically untreated WT mice.
  
  
  CONCLUSIONS
  ZnT3-KO mice revealed more damage after TBI compared to WT controls. Following treatment with DEDTC or selenium an increase in the number of both dead and apoptotic cells were seen in the controls within the first 24 hours after TBI while the degree of damage in the ZnT3-KO mice remained largely unchanged. Further analyses revealed that the damage development in the two mouse strains was almost identical after either zinc chelation or zinc complexion therapy.
authors.affiliation: Institute of Anatomy, Neurobiology, University of Aarhus, Aarhus, Denmark. pdj@neuro.au.dk
authors.forename: Peter
authors.initials: P
authors.lastname: Doering
authors.forename: Meredin
authors.initials: M
authors.lastname: Stoltenberg
authors.forename: Milena
authors.initials: M
authors.lastname: Penkowa
authors.forename: Jørgen
authors.initials: J
authors.lastname: Rungby
authors.forename: Agnete
authors.initials: A
authors.lastname: Larsen
authors.forename: Gorm
authors.initials: G
authors.lastname: Danscher
mesh_terms: D000818:Animals; D001930:Brain Injuries / Q000378:metabolism* / Q000473:pathology; D016923:Cell Death / Q000187:drug effects; D002490:Central Nervous System / Q000378:metabolism / Q000473:pathology*; D002614:Chelating Agents / Q000494:pharmacology; D004050:Ditiocarb / Q000031:analogs & derivatives / Q000494:pharmacology; D018698:Glutamic Acid; D051379:Mice; D018345:Mice, Knockout; D009474:Neurons / Q000187:drug effects / Q000473:pathology*; D018038:Sodium Selenite / Q000494:pharmacology; D015032:Zinc / Q000172:deficiency* / Q000378:metabolism
chemical_list: D002614:Chelating Agents; D018698:Glutamic Acid; D004050:Ditiocarb; D018038:Sodium Selenite; C039353:dihydroxyethyldithiocarbamate; D015032:Zinc
references.citation: J Physiol. 2005 Aug 1;566(Pt 3):821-37
references.pmid: 15919712
references.citation: J Alzheimers Dis. 2005 Nov;8(2):155-60; discussion 209-15
references.pmid: 16308484
references.citation: Histochem Cell Biol. 2008 Oct;130(4):681-92
references.pmid: 18542984
references.citation: J Pharmacol Sci. 2006 Feb;100(2):142-8
references.pmid: 16474205
references.citation: J Chem Neuroanat. 1996 Aug;11(2):99-111
references.pmid: 8877598
references.citation: Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12676-81
references.pmid: 9356509
references.citation: Nutr Neurosci. 2002 Oct;5(5):345-52
references.pmid: 12385597
references.citation: Neuroscience. 2007 Dec 5;150(2):357-69
references.pmid: 17949919
references.citation: Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1716-21
references.pmid: 9990090
references.citation: Neuroscience. 1990;38(3):843-54
references.pmid: 2176723
references.citation: Brain Res Brain Res Rev. 2000 Dec;34(3):137-48
references.pmid: 11113504
references.citation: J Neurosci. 2000 Jun 1;20(11):RC79
references.pmid: 10807937
references.citation: Brain Res. 1975 Mar 7;85(3):522-6
references.pmid: 163124
references.citation: Neuroscience. 2008 Dec 2;157(3):697-707
references.pmid: 18840509
references.citation: J Nutr. 2000 May;130(5S Suppl):1471S-83S
references.pmid: 10801962
references.citation: Epilepsy Res. 2000 Apr;39(2):153-69
references.pmid: 10759303
references.citation: Neuroscience. 2002;115(3):871-8
references.pmid: 12435425
references.citation: Nature. 1984 Apr 19-25;308(5961):734-6
references.pmid: 6717566
references.citation: Neuroscience. 2009 Jan 12;158(1):126-36
references.pmid: 18353558
references.citation: J Neurosci Methods. 2004 Oct 15;139(1):79-89
references.pmid: 15351524
references.citation: J Comp Neurol. 2004 Nov 8;479(2):156-67
references.pmid: 15452827
references.citation: Brain Res. 2001 Dec 7;921(1-2):165-72
references.pmid: 11720723
references.citation: Neuroscience. 1992;48(2):325-52
references.pmid: 1376449
references.citation: J Cereb Blood Flow Metab. 2006 Feb;26(2):161-9
references.pmid: 15988476
references.citation: Brain Res. 1989 Feb 20;480(1-2):317-21
references.pmid: 2713657
references.citation: Neuroscience. 2007 Nov 30;150(1):93-103
references.pmid: 17996379
references.citation: Brain Res. 1985 Jun 24;337(1):91-8
references.pmid: 2408711
references.citation: Trends Neurosci. 2000 Aug;23(8):365-71
references.pmid: 10906800
references.citation: Neuroscience. 2004;125(4):867-77
references.pmid: 15120848
references.citation: Neuroscience. 2001;105(4):941-7
references.pmid: 11530232
references.citation: Exp Brain Res. 1973 Mar 19;16(5):521-32
references.pmid: 4121158
references.citation: Epilepsia. 2006 May;47(5):887-99
references.pmid: 16686654
references.citation: Prog Histochem Cytochem. 2006;41(2):57-139
references.pmid: 16949439
references.citation: Mol Cell Neurosci. 2002 Oct;21(2):189-204
references.pmid: 12401442
references.citation: Neurosci Lett. 2002 Mar 15;321(1-2):37-40
references.pmid: 11872251
references.citation: Science. 1996 May 17;272(5264):1013-6
references.pmid: 8638123
references.citation: Eur J Neurosci. 2000 Jul;12(7):2311-22
references.pmid: 10947810
references.citation: Neurosci Lett. 2008 Aug 1;440(2):155-9
references.pmid: 18556117
references.citation: Neurosci Lett. 1999 Dec 24;277(2):75-8
references.pmid: 10624813
references.citation: Brain Res. 2000 Jan 10;852(2):268-73
references.pmid: 10678752
references.citation: J Neurochem. 2003 May;85(3):563-70
references.pmid: 12694382
references.citation: Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14934-9
references.pmid: 8962159
references.citation: Brain Res. 2001 Mar 23;895(1-2):25-32
references.pmid: 11259756
references.citation: Biometals. 2009 Feb;22(1):149-57
references.pmid: 19130267
references.citation: Synapse. 2009 Nov;63(11):1029-49
references.pmid: 19623531
references.citation: J Histochem Cytochem. 2008 Jan;56(1):3-6
references.pmid: 17712179
references.citation: Nature. 1984 Apr 19-25;308(5961):736-8
references.pmid: 6717567
references.citation: Brain Res. 1998 Nov 23;812(1-2):265-9
references.pmid: 9813362
references.citation: Exp Neurol. 2003 Nov;184(1):337-47
references.pmid: 14637104
references.citation: Biometals. 2001 Sep-Dec;14(3-4):343-51
references.pmid: 11831464
references.citation: Histochemistry. 1982;76(3):281-93
references.pmid: 6186642
references.citation: Brain Res. 2000 Aug 25;874(2):123-30
references.pmid: 10960596
references.citation: J Histochem Cytochem. 2005 Feb;53(2):141-53
references.pmid: 15684327